Khoo Teck Puat-National University Children's Medical Institute, National University Health System (NUHS), Singapore City, Singapore.
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore City, Singapore.
Allergy. 2024 Jun;79(6):1470-1484. doi: 10.1111/all.16044. Epub 2024 Feb 3.
The skin microbiome is an extensive community of bacteria, fungi, mites, viruses and archaea colonizing the skin. Fluctuations in the composition of the skin microbiome have been observed in atopic dermatitis (AD) and food allergy (FA), particularly in early life, established disease, and associated with therapeutics. However, AD is a multifactorial disease characterized by skin barrier aberrations modulated by genetics, immunology, and environmental influences, thus the skin microbiome is not the sole feature of this disease. Future research should focus on mechanistic understanding of how early-life skin microbial shifts may influence AD and FA onset, to guide potential early intervention strategies or as microbial biomarkers to identify high-risk infants who may benefit from possible microbiome-based biotherapeutic strategies. Harnessing skin microbes as AD biotherapeutics is an emerging field, but more work is needed to investigate whether this approach can lead to sustained clinical responses.
皮肤微生物组是一个广泛的细菌、真菌、螨虫、病毒和古菌群落,定植于皮肤。特应性皮炎(AD)和食物过敏(FA)中观察到皮肤微生物组组成的波动,特别是在生命早期、已确立的疾病中,并与治疗相关。然而,AD 是一种多因素疾病,其特征是皮肤屏障异常,受遗传、免疫和环境影响调节,因此皮肤微生物组不是该疾病的唯一特征。未来的研究应侧重于深入了解生命早期皮肤微生物群的变化如何可能影响 AD 和 FA 的发病,以指导潜在的早期干预策略,或作为微生物生物标志物来识别可能受益于基于微生物组的生物治疗策略的高危婴儿。利用皮肤微生物作为 AD 生物疗法是一个新兴领域,但需要做更多的工作来研究这种方法是否可以带来持续的临床反应。